A mitochondrial percentage needs its tissue beside it

Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.

A mitochondrial result may contain a percentage that looks like a direct measure of disease severity. It can instead describe heteroplasmy: a mixture of mitochondrial DNA variants in the material examined. Understanding that distinction prevents a technical proportion from becoming a personal prognosis.

Mitochondria have their own DNA, alongside the DNA in the cell nucleus. Mitochondrial conditions can involve either source. A mitochondrial test therefore needs a clear purpose and method, not just a percentage.

Many copies, possible mixtures

The MedlinePlus mitochondrial-DNA explanation provides the basic distinction between mitochondrial and nuclear genetic material. A mitochondrial result is not simply a standard two-copy autosomal genotype with a different gene name.

The NHS mitochondrial-inheritance resource discusses heteroplasmy and the complexity of mitochondrial inheritance. The concept helps explain why a simple family-tree calculation may not answer an individual question.

Here is a hypothetical teaching example. In a laboratory sample, some mitochondrial DNA copies carry one sequence and others carry another. A reported proportion describes that mixture under the laboratory's method. It does not say that the same proportion occurs in every organ or that a matching proportion of the person's health has been lost.

Numbers make this distinction particularly important. A result that says thirty per cent does not mean thirty per cent of the body is affected, thirty per cent of mitochondria are non-functional or a thirty per cent chance of developing a condition. Those are different claims.

The tissue can change the interpretation

The NHS mitochondrial-DNA testing explanation notes that heteroplasmic variants can occur at different levels across tissues. A variant absent from a blood sample may be detectable elsewhere in a relevant investigation.

That does not mean a reader should arrange a muscle biopsy or keep buying tests until a variant appears. Specimen selection is a clinical decision with practical and safety consequences. The source concerns investigating suspected mitochondrial conditions, not screening everyone who feels tired.

A hypothetical comparison illustrates why tissue labels matter. One report uses blood and another uses a different specimen. Even if both print the same variant name, you cannot treat their percentages as interchangeable measurements of a whole-body quantity.

The comparison also needs the method and collection context. A report's detection limit should remain part of its interpretation. “Not detected” should not be rewritten as “no mitochondrial condition is possible”.

Keep inheritance and symptoms separate

Mitochondrial inheritance is often introduced through the maternal line, but that alone does not predict a particular person's symptoms or a child's outcome. Conditions involving nuclear genes may follow other inheritance patterns. Heteroplasmy introduces additional complexity for mitochondrial-DNA variants.

For family questions, retain the actual laboratory report and the clinical interpretation. A generic chart from a search result cannot supply the information needed for reproductive counselling.

Likewise, a symptom such as low energy does not identify mitochondrial disease. The sources explain a category of genetic testing; they do not support matching an everyday experience to a mitochondrial diagnosis or a supplement plan.

A better way to summarise the report

A useful personal note can contain four items: the variant as written, the specimen, the reported proportion with its label, and the laboratory's conclusion. This is an editorial record-keeping suggestion, not a validated diagnostic tool.

If you compare reports, add whether they used the same method and tissue. Leave missing information visibly missing. Do not average percentages from different specimens to create a supposedly more representative number.

Ask what the reported proportion helps the clinical team understand and what it cannot establish. That invites an explanation of the actual result rather than a general discussion of whether a number is high or low.

What you can do with this

Your practical next step is to find the specimen field before interpreting a mitochondrial percentage. If the result has clinical significance or raises family questions, bring the complete report to the relevant genetics or mitochondrial service.

The percentage has a place in the assessment. Keeping its tissue and method beside it prevents it from being promoted into a prognosis it was never designed to provide.

For general lifestyle learning, DomDNA’s educational quiz does not interpret mitochondrial results or diagnose causes of fatigue.